Dr Daniel Adam Glass, MD - Medicare Otolaryngology in Tyler, TX

Dr Daniel Adam Glass, MD is a medicare enrolled "Otolaryngology" physician in Tyler, Texas. He graduated from medical school in 2007 and has 17 years of diverse experience with area of expertise as Otolaryngology. He is a member of the group practice Heaton Ear Nose And Throat Associates Of East Texas P A and his current practice location is 1136 E Grande Blvd, Tyler, Texas. You can reach out to his office (for appointments etc.) via phone at (903) 592-5601.

Dr Daniel Adam Glass is licensed to practice in Texas (license number P3333) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1487839981.

Contact Information

Dr Daniel Adam Glass, MD
1136 E Grande Blvd,
Tyler, TX 75703-3982
(903) 592-5601
(903) 595-3304



Physician's Profile

Full NameDr Daniel Adam Glass
GenderMale
SpecialityOtolaryngology
Experience17 Years
Location1136 E Grande Blvd, Tyler, Texas
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Daniel Adam Glass graduated from medical school in 2007
  NPI Data:
  • NPI Number: 1487839981
  • Provider Enumeration Date: 01/02/2008
  • Last Update Date: 12/09/2016
  Medicare PECOS Information:
  • PECOS PAC ID: 0244486744
  • Enrollment ID: I20120816000580

Medical Identifiers

Medical identifiers for Dr Daniel Adam Glass such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1487839981NPI-NPPES
305150001MedicaidTX
8DG792OtherTXBCBS

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207Y00000XOtolaryngology P3333 (Texas)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Christus Mother Frances HospitalTyler, TXHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Heaton Ear Nose And Throat Associates Of East Texas P A46887744827

News Archive

TUM scientists collaborate with Fujitsu Laboratories of Japan to commercialize biosensor chip

In the battle against cancer and other diseases, precise analysis of specific proteins can point the way toward targeted treatments. Scientists at theTechnische Universitaet Muenchen, together with Fujitsu Laboratories of Japan, have developed a novel biosensor chip that not only recognizes proteins that are characteristic for specific diseases, but also can show if these proteins are changed through the influence of disease or drugs.

Oral delivery of PYY hormone can help obese people lose weight

Most people understand that serious weight loss requires changing attitudes toward what they eat and how often they exercise. But, what if the process could be aided by simply chewing a stick of gum after meals? That's the question a team of scientists, led by Syracuse University chemist Robert Doyle, is trying to answer. In a groundbreaking new study, Doyle's team demonstrated, for the first time, that a critical hormone that helps people feel "full" after eating can be delivered into the bloodstream orally.

Lifestyle interventions benefit overweight, obese and severely obese adults

Lifestyle interventions, including physical activity and structured weight loss programs, can result in significant weight loss for overweight, obese and severely obese adults, according to two reports that were posted online today by JAMA. The studies and accompanying editorials were made available early online to coincide with the presentation of these papers at the 28th Annual Scientific Meeting of the Obesity Society. The articles will appear in the October 27 print issue of JAMA.

MacroGenics commences MGAH22 Phase I trail for patients with HER2-positive cancer

MacroGenics, a privately held biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases, today announced that it had administered drug to the first cohort of patients in a Phase I clinical trial of MGAH22.

Intrexon acquires Immunologix

SCRA, on behalf of its SC Launch program, today announced that Portfolio Company Immunologix has been acquired by Virginia-based synthetic biology company Intrexon Corporation. The Charleston-based Immunologix team is now part of Intrexon's Protein Production Division.

Read more Medical News

› Verified 4 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Daniel Adam Glass allows following entities to bill medicare on his behalf.
Entity NameHeaton Ear Nose And Throat Associates Of East Texas P A
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1306988035
PECOS PAC ID: 4688774482
Enrollment ID: O20090120000320

News Archive

TUM scientists collaborate with Fujitsu Laboratories of Japan to commercialize biosensor chip

In the battle against cancer and other diseases, precise analysis of specific proteins can point the way toward targeted treatments. Scientists at theTechnische Universitaet Muenchen, together with Fujitsu Laboratories of Japan, have developed a novel biosensor chip that not only recognizes proteins that are characteristic for specific diseases, but also can show if these proteins are changed through the influence of disease or drugs.

Oral delivery of PYY hormone can help obese people lose weight

Most people understand that serious weight loss requires changing attitudes toward what they eat and how often they exercise. But, what if the process could be aided by simply chewing a stick of gum after meals? That's the question a team of scientists, led by Syracuse University chemist Robert Doyle, is trying to answer. In a groundbreaking new study, Doyle's team demonstrated, for the first time, that a critical hormone that helps people feel "full" after eating can be delivered into the bloodstream orally.

Lifestyle interventions benefit overweight, obese and severely obese adults

Lifestyle interventions, including physical activity and structured weight loss programs, can result in significant weight loss for overweight, obese and severely obese adults, according to two reports that were posted online today by JAMA. The studies and accompanying editorials were made available early online to coincide with the presentation of these papers at the 28th Annual Scientific Meeting of the Obesity Society. The articles will appear in the October 27 print issue of JAMA.

MacroGenics commences MGAH22 Phase I trail for patients with HER2-positive cancer

MacroGenics, a privately held biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases, today announced that it had administered drug to the first cohort of patients in a Phase I clinical trial of MGAH22.

Intrexon acquires Immunologix

SCRA, on behalf of its SC Launch program, today announced that Portfolio Company Immunologix has been acquired by Virginia-based synthetic biology company Intrexon Corporation. The Charleston-based Immunologix team is now part of Intrexon's Protein Production Division.

Read more Medical News

› Verified 4 days ago

Entity NameFyzical Therapy & Balance Center Tyler Pllc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1831695998
PECOS PAC ID: 1254687395
Enrollment ID: O20180703002518

News Archive

TUM scientists collaborate with Fujitsu Laboratories of Japan to commercialize biosensor chip

In the battle against cancer and other diseases, precise analysis of specific proteins can point the way toward targeted treatments. Scientists at theTechnische Universitaet Muenchen, together with Fujitsu Laboratories of Japan, have developed a novel biosensor chip that not only recognizes proteins that are characteristic for specific diseases, but also can show if these proteins are changed through the influence of disease or drugs.

Oral delivery of PYY hormone can help obese people lose weight

Most people understand that serious weight loss requires changing attitudes toward what they eat and how often they exercise. But, what if the process could be aided by simply chewing a stick of gum after meals? That's the question a team of scientists, led by Syracuse University chemist Robert Doyle, is trying to answer. In a groundbreaking new study, Doyle's team demonstrated, for the first time, that a critical hormone that helps people feel "full" after eating can be delivered into the bloodstream orally.

Lifestyle interventions benefit overweight, obese and severely obese adults

Lifestyle interventions, including physical activity and structured weight loss programs, can result in significant weight loss for overweight, obese and severely obese adults, according to two reports that were posted online today by JAMA. The studies and accompanying editorials were made available early online to coincide with the presentation of these papers at the 28th Annual Scientific Meeting of the Obesity Society. The articles will appear in the October 27 print issue of JAMA.

MacroGenics commences MGAH22 Phase I trail for patients with HER2-positive cancer

MacroGenics, a privately held biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases, today announced that it had administered drug to the first cohort of patients in a Phase I clinical trial of MGAH22.

Intrexon acquires Immunologix

SCRA, on behalf of its SC Launch program, today announced that Portfolio Company Immunologix has been acquired by Virginia-based synthetic biology company Intrexon Corporation. The Charleston-based Immunologix team is now part of Intrexon's Protein Production Division.

Read more Medical News

› Verified 4 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Daniel Adam Glass is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Daniel Adam Glass, MD
1136 E Grande Blvd,
Tyler, TX 75703-3982

Ph: (903) 592-5601
Dr Daniel Adam Glass, MD
1136 E Grande Blvd,
Tyler, TX 75703-3982

Ph: (903) 592-5601

News Archive

TUM scientists collaborate with Fujitsu Laboratories of Japan to commercialize biosensor chip

In the battle against cancer and other diseases, precise analysis of specific proteins can point the way toward targeted treatments. Scientists at theTechnische Universitaet Muenchen, together with Fujitsu Laboratories of Japan, have developed a novel biosensor chip that not only recognizes proteins that are characteristic for specific diseases, but also can show if these proteins are changed through the influence of disease or drugs.

Oral delivery of PYY hormone can help obese people lose weight

Most people understand that serious weight loss requires changing attitudes toward what they eat and how often they exercise. But, what if the process could be aided by simply chewing a stick of gum after meals? That's the question a team of scientists, led by Syracuse University chemist Robert Doyle, is trying to answer. In a groundbreaking new study, Doyle's team demonstrated, for the first time, that a critical hormone that helps people feel "full" after eating can be delivered into the bloodstream orally.

Lifestyle interventions benefit overweight, obese and severely obese adults

Lifestyle interventions, including physical activity and structured weight loss programs, can result in significant weight loss for overweight, obese and severely obese adults, according to two reports that were posted online today by JAMA. The studies and accompanying editorials were made available early online to coincide with the presentation of these papers at the 28th Annual Scientific Meeting of the Obesity Society. The articles will appear in the October 27 print issue of JAMA.

MacroGenics commences MGAH22 Phase I trail for patients with HER2-positive cancer

MacroGenics, a privately held biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases, today announced that it had administered drug to the first cohort of patients in a Phase I clinical trial of MGAH22.

Intrexon acquires Immunologix

SCRA, on behalf of its SC Launch program, today announced that Portfolio Company Immunologix has been acquired by Virginia-based synthetic biology company Intrexon Corporation. The Charleston-based Immunologix team is now part of Intrexon's Protein Production Division.

Read more News

› Verified 4 days ago


Otolaryngology Doctors in Tyler, TX

Dr. Monica Jane Hardee, MD
Otolaryngology
Medicare: Accepting Medicare Assignments
Practice Location: 1136 E Grande Blvd, Tyler, TX 75703
Phone: 903-592-5601    Fax: 903-595-3304
Timothy Dale,
Otolaryngology
Medicare: Accepting Medicare Assignments
Practice Location: 1136 E Grande Blvd, Tyler, TX 75703
Phone: 903-592-5601    
James Dan Toney, MD
Otolaryngology
Medicare: Accepting Medicare Assignments
Practice Location: 630 S Fleishel Ave, Tyler, TX 75701
Phone: 903-533-1491    
Christopher A Perro, MD
Otolaryngology
Medicare: Accepting Medicare Assignments
Practice Location: 2210 Three Lakes Pkwy Ste 100, Tyler, TX 75703
Phone: 903-747-4050    Fax: 903-747-4075
Scott Fraser Kohlert, MD
Otolaryngology
Medicare: Accepting Medicare Assignments
Practice Location: 910 E Houston St Ste 530, Tyler, TX 75702
Phone: 903-606-4300    
Howard Scott Garb, MD
Otolaryngology
Medicare: Medicare Enrolled
Practice Location: 1136 E Grande Blvd, Tyler, TX 75703
Phone: 903-592-5601    Fax: 903-595-3304
John Franklin Hudnall, MD
Otolaryngology
Medicare: Not Enrolled in Medicare
Practice Location: 3413 Golden Rd, Tyler, TX 75701
Phone: 903-592-5601    Fax: 903-595-3304

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.